Clinical Trials Directory

Trials / Terminated

TerminatedNCT00070317

Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer

Lymphatic Mapping and Sentinel Node Identification in Patients With Stage1B1 Cervical Carcinoma

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
102 (actual)
Sponsor
Gynecologic Oncology Group · Network
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

This clinical trial is studying how well lymph node mapping and sentinel lymph node identification work in finding lymph node metastases in patients with stage IB1 cervical cancer. Diagnostic procedures, such as lymph node mapping and sentinel lymph node identification, performed before and during surgery, may improve the ability to detect lymph node metastases in patients who have cervical cancer.

Detailed description

OBJECTIVES: I. Determine the sensitivity of the sentinel lymph node in the determination of lymph node metastases, using preoperative or intraoperative lymphatic mapping, in patients with stage IB1 cervical cancer. II. Determine the false-negative predictive value of the sentinel lymph node in the determination of lymph node metastases in these patients. OUTLINE: This is a multicenter study. Patients receive radiolabeled technetium Tc 99m sulfur colloid injected around the tumor 6 hours prior to or after induction of anesthesia right before surgery. Patients then undergo radical hysterectomy and complete pelvic and low para-aortic lymphadenectomy. Intraoperatively, patients undergo lymphatic mapping and sentinel lymph node identification using isosulfan blue or methylene blue injected at 4 locations in the cervix and a hand-held gamma counter.

Conditions

Interventions

TypeNameDescription
DRUGIsosulfan BlueUndergo lymphangiography using isosulfan blue or methylene blue
PROCEDURELymph Node MappingUndergo lymphatic mapping
PROCEDURELymphangiographyUndergo lymphangiography using isosulfan blue or methylene blue
DRUGMethylene BlueUndergo lymphangiography using isosulfan blue or methylene blue
PROCEDURERadionuclide ImagingUndergo radionuclide imaging with technetium Tc 99m sulfur colloid
PROCEDURESentinel Lymph Node BiopsyUndergo complete pelvic and low para-aortic lymphadenectomy
RADIATIONTechnetium Tc-99m Sulfur ColloidUndergo radionuclide imaging with technetium Tc 99m sulfur colloid
PROCEDURETherapeutic Conventional SurgeryUndergo radical hysterectomy

Timeline

Start date
2004-06-01
Primary completion
2013-01-01
Completion
2013-01-01
First posted
2003-10-07
Last updated
2017-11-06
Results posted
2017-10-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00070317. Inclusion in this directory is not an endorsement.